These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2060128)

  • 21. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
    Igarashi K; Hirotani H; Woo JT; Stern PH
    Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cyclosporins A, G, and H on normal and ichthyotic keratinocyte growth in culture.
    Amsellem C; Haftek M; Kanitakis J; Thivolet J
    Arch Dermatol Res; 1992; 284(3):173-8. PubMed ID: 1503503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
    Fernandes JB; Naik UP; Markell MS; Kornecki E
    Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M; Bindschedler M; Costa E; Zuber M; Vozeh S; Thiel G; Abisch E; Keller HP; Beveridge T; Follath F
    Transplantation; 1988 Mar; 45(3):558-61. PubMed ID: 3347936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ; Yatscoff RW
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.
    Ryffel B; Donatsch P; Hiestand P; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S95-9. PubMed ID: 3458551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orally administered immunosuppressants modify intestinal uptake of nutrients in rabbits.
    Dias VC; Madsen KL; Yatscoff RW; Doring K; Thomson AB
    Transplantation; 1994 Dec; 58(11):1241-6. PubMed ID: 7992368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.
    Cvetkovic M; Mann GN; Romero DF; Liang XG; Ma Y; Jee WS; Epstein S
    Transplantation; 1994 Apr; 57(8):1231-7. PubMed ID: 7513912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins.
    Damaso CR; Moussatché N
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():339-46. PubMed ID: 9472618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Caspi RR; McAllister CG; Gery I; Nussenblatt RB
    Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and metabolism of cyclosporin G in humans.
    Mangold JB; Schran HF; Tse FL
    Drug Metab Dispos; 1994; 22(6):873-9. PubMed ID: 7895604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of P-glycoprotein by cyclosporin A analogues and metabolites.
    Demeule M; Laplante A; Sepehr-Araé A; Beaulieu E; Averill-Bates D; Wenger RM; Béliveau R
    Biochem Cell Biol; 1999; 77(1):47-58. PubMed ID: 10426286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of cyclosporin G in the mouse, rat, and dog.
    Mangold JB; Rodriguez LC; Wang YK
    Drug Metab Dispos; 1995 Jun; 23(6):615-21. PubMed ID: 7587942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine: a review and its specific use in liver transplantation.
    de Groen PC
    Mayo Clin Proc; 1989 Jun; 64(6):680-9. PubMed ID: 2473361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotoxicity of cyclosporine G and A in the Sprague-Dawley rat.
    Duncan JI; Simpson JG; Thomson AW; Whiting PH
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1391-2. PubMed ID: 3274338
    [No Abstract]   [Full Text] [Related]  

  • 36. Whole-blood cyclosporin G in renal transplant recipients determined by two immunoassays and liquid chromatography.
    McBride JH; Kim SS; Danovitch GM; Rodgerson DO; Reyes AF; Ota MK
    Clin Chem; 1993 Jul; 39(7):1415-9. PubMed ID: 8330399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoplasmic membrane potential of mouse lymphocytes is decreased by cyclosporins.
    Damjanovich S; Aszalos A; Mulhern S; Balazs M; Matyus L
    Mol Immunol; 1986 Feb; 23(2):175-80. PubMed ID: 3517621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo fluorescence microscopy of kidney subcapsular blood flow in mice. Effects of cyclosporine, (NVA2)-cyclosporine, and isradipine, a new calcium antagonist.
    Rooth P; Dawidson I; Clothier N; Diller K
    Transplantation; 1988 Oct; 46(4):566-9. PubMed ID: 2972094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effectiveness of cyclosporine A, D, and G in the treatment of experimental autoimmune uveitis in rats.
    Nussenblatt RB; Caspi RR; Dinning WJ; Palestine AG; Hiestand P; Borel J
    J Immunopharmacol; 1986; 8(3):427-35. PubMed ID: 3489788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.